Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,074 total articles
Global Mofy AI Limited (Nasdaq: GMM), a generative AI technology solutions provider specializing in virtual content production and 3D digital assets, announced its application to join the Snowflake Partner Network. This move aims to expand its global technology ecosystem and improve digital content data capabilities to support various sectors inclu…
Bogota Financial Corp., the holding company for Bogota Savings Bank, announced a merger agreement with GSL Savings Bank. The merger will increase Bogota Financial's consolidated assets to approximately $1 billion. Post-merger, GSL's CEO will join Bogota as Executive Vice President and COO. The transaction is expected to close in the second half of …
CECO Environmental Corp., a Nasdaq-listed company, announced the completion of its acquisition of Thermon Group Holdings, enhancing CECO's capabilities in industrial process heating and expanding its engineered solutions portfolio. The combined entity aims to drive long-term shareholder value and capitalize on key global industrial and environmenta…
T3 Defense Inc.'s wholly owned subsidiary Rimon agencies is progressing in manufacturing and delivering mobile counter-drone launcher platforms for Elbit Systems’ Active Defense division in Israel. These mobile systems integrate energy management, climate control, and stabilized sensors in trailers for rapid deployment and sustained operations with…
Enviri II Corporation has completed its spin-off as New Enviri, an independent publicly traded company on the NYSE under ticker NVRI. The spin-off follows the sale of its Clean Earth business to Veolia. New Enviri focuses on environmental solutions for industrial waste and rail sector technology, operating through its Harsco Environmental and Harsc…
Oncolytics Biotech announced promising initial preclinical data showing enhanced anti-tumor activity when their immunotherapy pelareorep is combined with RAS pathway inhibitors in solid tumor models. These findings support further studies in pancreatic and colorectal cancers that harbor RAS mutations, aiming to improve immune activation and treatme…
Alpha Tau Medical announced positive overall survival and favorable safety results from a pooled analysis of three Phase I/II clinical studies of its Alpha DaRT therapy in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma. The treatment demonstrated median overall survival times notably exceeding historical data in secon…
Exagen Inc. announced publication of a systematic review confirming that its AVISE Lupus diagnostic test uniquely identifies 25% of lupus patients missed by conventional markers, demonstrating high accuracy and consistency across over 1,200 patients and 14 medical centers. This real-world evidence supports earlier diagnosis and intervention in Syst…
ARRAY Technologies announces an update to its OmniTrack® terrain-following solar tracker, increasing its flex capability between posts from 1° to 2°, enabling greater design flexibility, reduced construction costs, and faster deployment by minimizing site grading. The enhanced OmniTrack supports shorter pile lengths and less site disturbance, which…
HUHUTECH International Group announced that its German subsidiary received seven purchase orders totaling approximately €13.9 million ($15 million) from a leading European advanced-node semiconductor wafer fabrication operator. Initial deposits have been received and revenue recognition is expected over fiscal years 2026 and 2027. The contract stre…
Zoom Communications announced the launch of ZoomMate, a new AI teammate designed to integrate conversational context from meetings with enterprise systems like Salesforce, Jira, Slack, and ServiceNow, enabling seamless transition from discussion to execution. ZoomMate leverages advanced agentic AI capabilities, including enterprise search, workflow…
AIM ImmunoTech has announced early completion of patient enrollment in its Phase 2 DURIPANC trial testing Ampligen combined with AstraZeneca's Imfinzi for metastatic pancreatic cancer. This milestone accelerates the study timeline with primary endpoint evaluation planned for December 2026. The company highlights encouraging survival, safety, and qu…
LIXTE Biotechnology Holdings, Inc. announced a strategic transformation from a clinical-stage pharmaceutical company into an AI energy infrastructure equipment and services platform. The company will focus on addressing the growing power demands of AI and hyperscale data centers in North America. Stuart D. Porter, founder of Denham Capital, with ex…
Syntec Optics (Nasdaq: OPTX), a U.S.-based leader in optics and photonics manufacturing for defense, space, and biomedical technologies, announced its inclusion in the Russell 3000 Index effective June 26, 2026. This milestone reflects the company's meeting of key market capitalization and liquidity thresholds and is expected to increase institutio…
Outlook Therapeutics announced it has resubmitted its Biologics License Application (BLA) to the U.S. FDA for ONS-5010/LYTENAVA™, a treatment for neovascular age-related macular degeneration (nAMD). Following a successful appeal of a previous Complete Response Letter, the FDA confirmed substantial evidence of effectiveness for the drug and classifi…
Verisk Analytics introduced a reengineered U.S. Tropical Cyclone (hurricane) model delivered via its cloud-native Synergy Studio platform. The update incorporates advanced climate science, enhanced hazard and vulnerability modeling, and improved representation of storm surge, wind, and inland flooding risks. Designed to provide insurers, reinsurers…
Fusemachines Inc., a NASDAQ-listed provider of enterprise AI products and services, has appointed Dr. Julia Hirschberg, a distinguished AI researcher and educator, to its Board of Directors. Dr. Hirschberg brings extensive expertise in natural language processing, speech technology, and AI governance, enhancing Fusemachines' commitment to responsib…
Maris-Tech Ltd. has announced the development of Venus-Space, an advanced AI-powered edge video processing platform tailored for low Earth orbit nano satellites. Leveraging upgraded capabilities from its Venus-Pro system, Venus-Space enables ultra-high-resolution video acquisition, onboard AI inference, and real-time streaming, significantly reduci…
ParaZero Technologies Ltd., an aerospace defense company specializing in smart autonomous air systems, announced its first order from a major U.S.-based Tier-1 defense corporation for its DefendAir Net Pods. This order supports integration of ParaZero's non-explosive, net-based Counter-UAS interception technology into advanced autonomous defense ap…
Uniti Group Inc. announced the commencement of a $1.14 billion offering of secured fiber network revenue term notes backed by residential fiber assets across multiple U.S. states. The notes are expected to mature in June 2033, with proceeds intended for general corporate purposes such as capital expenditures and debt repayment. The offering is targ…
Rezolve Ai PLC, trading on NASDAQ as RZLV, reaffirmed its FY26 revenue guidance of approximately $360 million, demonstrating strong confidence backed by accelerating enterprise adoption and conversion of its commercial pipeline. The company reported Q1 2026 revenue of $60 million, surpassing its total 2025 revenue, highlighting significant growth d…
Wave Life Sciences Ltd., a clinical-stage biotechnology company specializing in RNA medicines, announced that its CEO will participate in two major healthcare investor conferences in June 2026. These events provide an opportunity to showcase the company's innovative RNA platform and diverse clinical pipeline targeting various genetic diseases.
Disc Medicine has initiated an expanded access program for its oral GlyT1 inhibitor, bitopertin, allowing eligible U.S. patients with erythropoietic protoporphyria (EPP) early access prior to regulatory approval. Bitopertin is currently in a Phase 3 trial with topline data expected in Q4 2026 and a potential FDA decision anticipated by mid-2027, ai…
Plexus Corp. has released its Fiscal 2025 Sustainability Report, marking a strategic move from intensity-based to absolute emission reduction targets. The company commits to reducing emissions by 2033, has doubled its zero waste sites, enhanced social impact contributions, and improved team member well-being programs, underscoring its dedication to…
IN8bio announced updated clinical data showing that repeat dosing of DeltEx DRI, a gamma-delta T cell therapy, combined with standard-of-care treatment significantly improved median progression-free and overall survival in newly diagnosed glioblastoma patients. Median overall survival exceeded 19.5 months, roughly 48% longer than with standard care…
